Value of NT-proBNP, CHA2DS2-VASc score combined with echocardiography in predicting prognosis of patients with atrial fibrillation
10.3760/cma.j.cn431274-20240815-01255
- VernacularTitle:NT-proBNP、CHA2DS2-VASc评分联合心脏彩超预测心房颤动患者预后的价值
- Author:
Li LI
1
;
Mengmeng CHEN
1
;
Liangyu CHEN
1
Author Information
1. 安徽医科大学附属滁州医院（滁州市第一人民医院）心血管内科，滁州 239000
- Publication Type:Journal Article
- Keywords:
Atrial fibrillation;
Prognosis;
N-terminal brain natriuretic peptide precursor;
CHA2DS2-VASc score;
Cardiac color ultrasound
- From:
Journal of Chinese Physician
2025;27(7):977-982
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the value of N-terminal brain natriuretic peptide precursor (NT-proBNP), CHA2DS2-VASc score combined with echocardiography in predicting the prognosis of patients with atrial fibrillation (AF).Methods:A retrospective analysis was performed on 320 AF patients admitted to the First People′s Hospital of Chuzhou from January 2022 to June 2024. All patients completed echocardiography, NT-proBNP blood sample testing, and CHA2DS2-VASc assessment. They were followed up for 6 months or until the occurrence of endpoint events (stroke or all-cause death). According to the prognosis, patients were divided into the endpoint event group and the good prognosis group. The clinical data of the two groups were compared. Multivariate logistic regression analysis was used to screen the influencing factors of endpoint events in AF patients. Receiver operating characteristic (ROC) curve was applied to analyze the predictive value of NT-proBNP, CHA2DS2-VASc score and echocardiography for the prognosis of AF patients.Results:By the end of follow-up, among 320 AF patients, 64 cases (20.00%) had endpoint events, including 33 cases (10.31%) of stroke and 31 cases (9.69%) of all-cause death; 256 cases (80.00%) had no endpoint events. The age, CHA2DS2-VASc score, proportion of New York Heart Association (NYHA) cardiac function grade Ⅳ, proportion of complicated type 2 diabetes, proportion of complicated peripheral vascular disease, left atrial diameter (LAD), left ventricular end systolic diameter (LVESD), left ventricular end diastolic diameter (LVEDD), logarithm of NT-proBNP, and C-reactive protein (CRP) level in the endpoint event group were all higher than those in the good prognosis group (all P<0.05). The hemoglobin (Hb) level, left ventricular ejection fraction (LVEF), and proportions of lipid-lowering and anticoagulant drug treatments were lower than those in the good prognosis group (all P<0.05). Multivariate logistic regression analysis showed that CHA2DS2-VASc score and NT-proBNP were independent risk factors for poor prognosis in AF patients (all P<0.05), and anticoagulant and lipid-lowering drug treatments were independent protective factors (all P<0.05). The sensitivity, specificity, and area under the ROC curve (AUC) of NT-proBNP, CHA2DS2-VASc score combined with echocardiography in predicting the prognosis of AF patients were 90.63%, 95.31%, and 0.927, respectively. The specificity and AUC of the combined prediction were higher than those of single assessment (all P<0.05), and there was no significant difference in sensitivity compared with single prediction (all P>0.05). Conclusions:NT-proBNP, CHA2DS2-VASc score, and echocardiography all have certain predictive value for the prognosis of AF patients, but the combined prediction value of the three is higher.
